Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Focal Adhesion Protein-Tyrosine Kinases × Plasma cell × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 117 Lenalidomide 75 daratumumab 63 Bortezomib 54 pomalidomide 41 Calcium Dobesilate 40 carfilzomib 39 Cyclophosphamide 33 Specimen Handling 27 Biopsy 24 Magnetic Resonance Spectroscopy 20 talquetamab 19 isatuximab 19 fludarabine 19 dexamethasone acetate 16 dexamethasone 21-phosphate 16 belantamab mafodotin 16 auricularum 16 iberdomide 15 selinexor 14 elotuzumab 10 tocilizumab 9 fludarabine phosphate 8 X-Rays 8 venetoclax 7 ixazomib 7 trametinib 6 Whole-Body Irradiation 6 Phantoms, Imaging 6 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05695508 2025-12-24

HD10/DSMMXX

University of Heidelberg Medical Center

Phase 2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡